Clinical Trial Update: Impact of Intravenous Iron Repletion On Mechanisms of Exercise InTolerance in HFpEF (IRONMET-HFpEF) [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial evaluating intravenous iron repletion to improve exercise tolerance mechanisms in patients with iron deficiency and heart failure with …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure with Preserved Ejection Fraction
• Iron Deficiency

Drugs mentioned

• Intravenous iron

Snippet

Sponsor: Massachusetts General Hospital | Conditions: Iron-deficiency, Heart Failure With Preserved Ejection Fraction | Phase 4 | Status: RECRUITING